Palavras-chave
Qualidade de Vida
Atividades Cotidianas
Gravidade da Doença
Inquéritos e Questionários
Como Citar
Resumo
Objetivou-se avaliar o impacto da psoríase na qualidade de vida - Quality of Life (QoL) - dos pacientes através do DLQI e do PDI, e sua correlação entre os escores globais e seus domínios individuais e o PASI. Aplicaram-se questionários DLQI e PDI a 58 pacientes acima de 18 anos de idade. Quanto maior o escore, mais afetada a QoL. O PASI, avaliação da gravidade e extensão da doença, correlacionou-se ao DLQI e ao PDI e aos domínios individuais de cada questionário utilizando-se da análise de correlação de Spearman (p-valor de 5%). O estudo seguiu as diretrizes Strengthening the Reporting of Observational Studies in Epidemiology para estudos observacionais. As médias foram, DLQI 7,6±7,4; PDI 11,3±8,6; PASI12±12,5. Constatou-se equivalência entre DLQI e PDI, rs=0,78; p=0,0001; associação significativa entre DLQI e PASI, rs=0,26; p=0,0003; entre PDI e PASI, rs=0,29; p=0,005. No DLQI, o PASI se correlacionou de forma mais significativa com sinais/sintomas, atividades diárias e relações pessoais, rs=0,35; rs=0,24; rs=0,16. No PDI, a relação foi maior com trabalho, relações pessoais e atividades diárias, rs=0,38; rs=0,20; rs=0,19. Foram utilizados os instrumentos específicos para doenças dermatológicas (DLQI) e para psoríase (PDI), que se mostraram correlatos e equivalentes e mostraram claramente o grande impacto negativo da psoríase na QoL, com relação linear entre PASI, DLQI e PDI.
Referências
Geng RSQ, Sibbald RG. Cutaneous psoriasis: clinical aspects and treatments. Adv Skin Wound Care. 2025;38(4):176-82. https://doi.org/10.1097/ASW.0000000000000243
López-Ferrer A, Laiz A, Puig L. Psoriatic arthritis. Med Clin (Barc). 2022;159(1):40-6. https://doi.org/10.1016/j.medcli.2022.01.024
Roenigk HH Jr, Maibach HI. Psoriasis. 3rd ed. New York: Marcel Dekker; 1998.
Morariu SH, Cotoi OS, Tiucă OM, Ambros M, Ilcuș RI, Garaga L, et al. Predicting factors and clinical characteristics of pruritus in psoriasis: a cross-sectional survey. Life (Basel). 2024;14(7):827. https://doi.org/10.3390/life14070827
Londoño-García AM, Castro-Ayarza JR, Franco Franco MD, González Ardila CF, Magariños G, Rivas Zaldívar ES, et al. Latin American consensus on psoriasis severity classification. An Bras Dermatol. 2025;100(3):539-47. https://doi.org/10.1016/j.abd.2024.09.010
Hawro M, Sahin E, Steć M, Różewicka-Czabańska M, Raducha E, Garanyan L, et al. A comprehensive, tri-national, cross-sectional analysis of characteristics and impact of pruritus in psoriasis. J Eur Acad Dermatol Venereol. 2022;36(11):2064-75. https://doi.org/10.1111/jdv.18330
Jaworecka K, Rzepko M, Marek-Józefowicz L, Tamer F, Stefaniak AA, Szczegielniak M, et al. The impact of pruritus on the quality of life and sleep disturbances in patients suffering from different clinical variants of psoriasis. J Clin Med. 2022;11(19):5553. https://doi.org/10.3390/jcm11195553
Gisondi P, Puig L, Richard MA, Paul C, Nijsten T, Taieb C, et al. Quality of life and stigmatization in people with skin diseases in Europe: a large survey from the Burden of Skin Diseases EADV project. J Eur Acad Dermatol Venereol. 2023;37(7):6-14. https://doi.org/10.1111/jdv.18917
Silverberg JI, Skayem C, Flavigny AD, Le Floc'h C, Merhand S, Begolka WS, et al. Chronic skin diseases and life trajectories: development and validation of Dermatology Long-Term Life Impact Measure. J Am Acad Dermatol. 2026;94(1):81-7. https://doi.org/10.1016/j.jaad.2025.08.042
Armstrong AW, Bohannan B, Mburu S, Coates LC, Ogdie A, Alarcon I, et al. Patient perspectives on psoriatic disease burden: results from the Global Psoriasis and Beyond Survey. Dermatology. 2023;239(4):621-34. https://doi.org/10.1159/000528945
Ghezzi G, Costanzo A, Borroni RG. Health-related quality of life in psoriasis: literature review. J Clin Med. 2024;13(16):4623. https://doi.org/10.3390/jcm13164623
Zhong H, Yang H, Mao Z, Chai X, Li S. Impact of moderate-to-severe psoriasis on quality of life in China: a qualitative study. Health Qual Life Outcomes. 2021;19(1):271. https://doi.org/10.1186/s12955-021-01902-w
Nabieva K, Vender R. Quality of life and body region affected by psoriasis: a systematic review. Actas Dermosifiliogr. 2023;114(1):33-8. https://doi.org/10.1016/j.ad.2022.07.021
Duran S, Yürekli A. Quality of life and satisfaction with life in patients with skin diseases. Psychol Health Med. 2023;28(10):2848-59. https://doi.org/10.1080/13548506.2023.2182893
Fredriksson T, Pettersson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica. 1978;157(4):238-44. https://doi.org/10.1159/000250839
Song WJ, Yoon HS. Impact of residual skin lesions and previous biologic treatment failure on patient-reported outcomes in patients with psoriasis receiving biologic treatment. J Dermatol. 2024;51(6):772-8. https://doi.org/10.1111/1346-8138.17249
López-Mejía R, Ramales-Montes EM, Ley-Silva LS, Romero-Sansalvador CY, Gutiérrez-Gabriel. Quality of life, depression and its relation to the severity in psoriasis. Rev Med Inst Mex Seguro Soc. 2022;60(3):315-20.
Boswell ND, Cook MK, Balogh EA, Feldman SR. The impact of complete clearance and almost complete clearance of psoriasis on quality of life: a literature review. Arch Dermatol Res. 2023;315(4):699-706. https://doi.org/10.1007/s00403-022-02420-5
Blackstone B, Patel R, Bewley A. Assessing and improving psychological well-being in psoriasis: considerations for the clinician. Psoriasis (Auckl). 2022;12:25-33. https://doi.org/10.2147/PTT.S328447
Kantor J. July 2021: quality of life and patient-reported outcome measures in dermatology. J Am Acad Dermatol. 2021;85(1):35. https://doi.org/10.1016/j.jaad.2021.04.094
Vyas J, Johns JR, Trivedi A, Ali FM, Ingram JR, Salek S, et al. Systematic review of the use of the Dermatology Life Quality Index in routine clinical practice: evidence from 287 articles across 56 countries. Clin Exp Dermatol. 2025;50(12):2456-65. https://doi.org/10.1093/ced/llaf343
Lewis VJ, Finlay AY. Two decades experience of the Psoriasis Disability Index. Dermatology. 2005;210(4):261-8. https://doi.org/10.1159/000084748
Vyas J, Johns JR, Ali FM, Ingram JR, Salek S, Finlay AY. A systematic review of 207 studies describing validation aspects of the Dermatology Life Quality Index. Acta Derm Venereol. 2024;104:adv41120. https://doi.org/10.2340/actadv.v104.41120
Nawaz S, Tapley A, Davey A, van Driel ML, Fielding A, Holliday E, et al. Management of a chronic skin disease in primary care: an analysis of early-career general practitioners' consultations involving psoriasis. Dermatol Pract Concept. 2021;11(3):e2021055. https://doi.org/10.5826/dpc.1103a55
Jorge HZ, Müller MC, Ferreira VRT, Cassal C. Pacientes portadores de dermatoses: relações iniciais e auto-agressividade. Psic (Vetor Ed). 2004;5(2):22-5.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-6. https://doi.org/10.1111/j.1365-2230.1994.tb01167.x
Zaino M, Parks E, McNeil J, Feldman S. Patients' preferences regarding modes of systemic psoriasis treatment: a qualitative study. J Psoriasis Psoriatic Arthritis. 2024;9(4):136-42. https://doi.org/10.1177/24755303241253200
Royeck S, Bamidis AD, Weckbecker C, et al. Treatment preferences among systemic therapy-naïve patients with atopic dermatitis or psoriasis in Germany: a multicentre study. Dermatol Ther (Heidelb). 2026;16(4):977-92. https://doi.org/10.1007/s13555-025-01615-8
Merola JF, Ogdie A, Gottlieb AB, Stein Gold L, Flower A, Jardon S, et al. Patient and physician perceptions of psoriatic disease in the United States: results from the UPLIFT Survey. Dermatol Ther (Heidelb). 2023;13(6):1329-46. https://doi.org/10.1007/s13555-023-00929-9
Nguyen CTH, Thi Mai Nguyen X, The Van T. Patient-centred preferences for biologic therapies in moderate to severe psoriasis in Vietnam: a discrete choice experiment. Acta Derm Venereol. 2025;105:adv42840. https://doi.org/10.2340/actadv.v105.42840
Sommer R, Mrowietz U, Gaarn Du Jardin K, Kasujee I, Martini E, Daudén E, et al. Implementing well-being in the management of psoriasis: an expert recommendation. J Eur Acad Dermatol Venereol. 2024;38(2):302-10. https://doi.org/10.1111/jdv.19567
Daudén E, Belinchón I, Colominas-González E, Coto P, de la Cueva P, Gallardo F, et al. Defining well-being in psoriasis: a Delphi consensus among healthcare professionals and patients. Sci Rep. 2024;14(1):14519. https://doi.org/10.1038/s41598-024-64738-6
Finlay AY. Current severe psoriasis and the rule of tens. Br J Dermatol. 2005;152(5):861-7. https://doi.org/10.1111/j.1365-2133.2005.06502.x
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2026 Global Academic Nursing Journal